American Urological Association, Inc.

The American Urological Association (AUA) is a premier professional organization dedicated to advancing urological clinical care. Founded in 1902, its mission is to promote the highest standards of urological clinical care through education, research, and the formulation of health care policy. The AUA is headquartered in Linthicum, Maryland, near Baltimore.

The AUA provides a wide array of services and resources to the urologic community, including comprehensive educational opportunities such as its Annual Meeting, courses, webinars, and leadership development programs. It actively supports urological research through funding, advocacy, and its Research Scholars Program, and publishes scientific content in The Journal of Urology and AUANews. Additionally, the AUA engages in significant advocacy efforts in Washington D.C. to influence health policy, offers data and statistical services, and develops evidence-based clinical practice guidelines. The association serves over 25,000 members worldwide, encompassing urologists, allied health professionals, researchers, and medical students.

In recent leadership changes, Lane Palmer, MD, assumed the role of AUA President for the 2025-2026 term, with Eugene Y. Rhee, MD, MBA, named President-Elect for the same period. A notable development in April 2026 was the AUA's collaboration with OpenEvidence, an AI-powered clinical decision support platform, to integrate AUA Clinical Practice Guidelines, aiming to expand access to evidence-based guidance for clinicians. The AUA continues to be a leading advocate for the specialty, consistently developing innovative, evidence-based education and strategically engaging with emerging technologies like AI to shape future clinical decision-making.

Latest updates

AUA Integrates Guidelines into AI Platform to Shape Clinical Decision Support

Event summary

  • The American Urological Association (AUA) and OpenEvidence have launched a multi-year collaboration.
  • The agreement will make AUA Clinical Practice Guidelines and Clinical Consensus Statements accessible within the OpenEvidence platform.
  • OpenEvidence is described as the most widely used medical AI platform among U.S. physicians, with hundreds of thousands of verified clinicians.
  • AUA has over 25,000 members worldwide and is headquartered near Baltimore, Maryland.
  • Lane Palmer, MD, serves as president of the AUA.

The big picture

The AUA’s proactive move to integrate its guidelines into an AI platform like OpenEvidence signals a broader shift in how medical societies engage with the rapidly evolving landscape of clinical decision support. This collaboration acknowledges the increasing influence of AI in medical practice and positions the AUA to shape its development rather than react to it. The partnership also highlights the growing importance of data provenance and authoritative sources in AI-driven healthcare, as clinicians and institutions seek reliable and evidence-based guidance.

What we're watching

Data Transparency
The success of this partnership hinges on AUA’s ability to maintain control over its guidelines’ integrity and usage data, preventing OpenEvidence from misrepresenting or misapplying the information.
Adoption Rate
Widespread adoption of the integrated guidelines within clinical workflows will be crucial for demonstrating the partnership's value and justifying further investment in AI-driven clinical decision support.
Competitive Response
Other medical societies will likely follow AUA’s lead, creating a race to integrate guidelines into AI platforms, potentially commoditizing this valuable content.
CID: 2329